XML 27 R17.htm IDEA: XBRL DOCUMENT
v3.22.1

Stock-Based Compensation | 6 Months Ended
--- | ---
Mar. 31, 2022
Share-based Payment Arrangement, Noncash Expense [Abstract] |
Stock-Based Compensation | Note 11: Stock-Based Compensation Our 2014 Omnibus Equity Incentive Plan (the “2014 Plan”) authorizes the issuance of distribution equivalent rights, incentive stock options, non-qualified stock options, performance stock, performance units, restricted ordinary shares, restricted stock units, stock appreciation rights, tandem stock appreciation rights and unrestricted ordinary shares to our directors, officer, employees, consultants and advisors. The Company has reserved up to 300,000 shares of common stock for issuance under the 2014 Plan. From time to time, the Company grants stock options to directors, officers, and employees. These awards are valued at the grant date by determining the fair value of the instruments. The value of each award is amortized on a straight-line basis over the requisite service period. The following table summarizes stock option activity for the fiscal year ended September 30, 2021 and the six months ended March 31, 2022:
|  | Number of Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Life |  |  | Intrinsic Value |
Outstanding at September 30, 2020 |  |  | 119,168 |  |  | $ | 15.76 |  |  |  | 2.71 |  |  | $ | — |
Granted |  |  | 7,500 |  |  |  | 40.92 |  |  |  |  |  |  |
Exercised |  |  | (28,668 | ) |  | 11.25 |  |  |  |  |  |  |
Forfeited |  |  | (10,500 | ) |  | 20.56 |  |  |  |  |  |  |
Outstanding at September 30, 2021 |  |  | 87,500 |  |  | $ | 18.81 |  |  |  | 1.78 |  |  | $ | 1,626 |
Exercisable at September 30, 2021 |  |  | 78,500 |  |  | $ | 16.29 |  |  |  | 1.72 |  |  | $ | 1,626 |
Outstanding at September 30, 2021 |  |  | 87,500 |  |  | $ | 18.81 |  |  |  | 1.78 |  |  | $ | 1,626 |
Granted |  |  | — |  |  | $ | — |  |  |  |  |  |  |
Exercised |  |  | — |  |  | $ | — |  |  |  |  |  |  |
Outstanding at March 31, 2022 |  |  | 87,500 |  |  | $ | 18.81 |  |  |  | 1.28 |  |  | $ | 2,193 |
Exercisable at March 31, 2022 |  |  | 82,500 |  |  | $ | 17.53 |  |  |  | 1.23 |  |  | $ | 2,144 |
The Company recognized compensation expense of approximately $19,000 and $270,000 during the three months ended March 31, 2022 and 2021, respectively, and approximately $37,000 and $287,000 during the six months ended March 31, 2022 and 2021, respectively, related to stock option awards granted to certain employees and officers based on the grant date fair value of the awards, and the revaluation for existing options whereby the expiration date was extended. As of March 31, 2022, the Company had no unrecognized compensation expense associated with stock option awards. The following table summarizes information about the Company’s non-vested shares outstanding as of March 31, 2022:
Non-vested Shares |  | Number of Shares |  |  | Average Grant-Date Fair Value |
Non-vested at September 30, 2021 |  |  | 9,000 |  |  | $ | 17.57 |
Granted |  |  | — |  |  | $ | — |
Vested |  |  | (4,000 | ) |  | $ | 20.74 |
Non-vested at March 31, 2022 |  |  | 5,000 |  |  | $ | 15.04 |

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration